Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer

Abstract

This study demonstrates that combining tumor features, radiomics, and ctDNA analysis improves outcome prediction in NSCLC treated with CRT therapy. Our integrated model could enable personalized and response-adapted therapies to reduce toxicity and improve outcomes in patients.